Pharmaceutical formulation for the treatment of diabetes...

Details Pharmaceutical formulation for the treatment of diabetes... Pharmaceutical formulation for the treatment of diabetes...

A - Human Necessities

61

K

167/103.42

A61K 38/28 (2006.01)

Patent

CA 1332354

ABSTRACT OF THE INVENTION Pharmaceutical formulation containing at least one insulin derivative modified with a base in position B31 of the insulin B chain and having an isoelectric point between 5.8 and 8.5 and/or at least one of its physiologically tolerated salts in a pharmaceutically acceptable excipient and a relatively high zinc ion content in the range from above 1 µg to about 200 µg of zing/IU. The preferred insulin derivative modified with a base for this pharmaceutical formulation is human insulin-B31- Arg-OH and human insulin-B31-Arg-B32-Arg-OH. The formulation is used for the treatment of diabetes mellitus; it has a particularly favorable action profile.

608115

Affiliated with

Also associated with

Rating

Pharmaceutical formulation for the treatment of diabetes... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical formulation for the treatment of diabetes..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulation for the treatment of diabetes... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1170263